The MCG Patent Portfolio

To give you an idea of the type of inventions we have under development, see the list given below. A non-confidential summary and additional information will be provided for any of these technologies upon request. You may also access this information online in "Technologies Available for License". Note that our list grows faster than we can even update the website, so the best approach is to call or write with your specific needs or areas of interest. 

  • Method of detecting and grading dysplasia in epithelial tissue
  • A method for light-curing resin adhesives for orthodontics brackets
  • Small RNAs that bind to Ku protein and inhibit DNA-PK activity
  • Regulation of T-cell-medicated immunity by tryptophan
  • High affinity tryptophan transporters
  • Method of reducing dentin sensitivity and compositions thereof
  • A fluoride-releasing dental amalgam restoration material
  • A fluorescent agent for the identification of tooth dentin
  • D-1 like dopamine receptor activity modifying protein
  • Screen for risk of gastric carcinoma
  • Glucose-dependent insulinotropic peptide as an osteoporic hormone
  • Long terminal repeat enhancer & insulator sequences for recombinant vectors
  • Pyridinium compounds
  • Effect of Rho kinase inhibitors on the erectile response
  • Educational modules on research clinical trials compliance

 

 

 

 

 

 

 

 

Revised May 5, 2009.   Please send comments, suggestions or questions about this page to Charles Nawrot, Ph.D., Associate Vice President, cnawrot@mcg.edu .